Universidade Anhanguera de São Paulo (UNIAN), Programa de Mestrado Profissional em Farmácia, São Paulo, SP, Brazil.
Universidade Federal de São Paulo (UNIFESP), Departamento de Fonoaudiologia, São Paulo, SP, Brazil.
Braz J Otorhinolaryngol. 2020 Nov-Dec;86(6):734-742. doi: 10.1016/j.bjorl.2019.05.003. Epub 2019 Jun 18.
Tinnitus is defined as the perception of sound without its actual presence in the environment. It has been the subject of a great number of studies, especially considering its consequences on patient's quality of life.
This study aimed to investigate the effect of hearing aids and/or Ginkgo biloba extract EGb 761 on tinnitus in patients with hearing loss.
This is a trial randomized-controlled treatment, parallel, double-blind, with three-arm. Thirty-three adults subjects were divided into three groups: group 1 - subjects undergoing drug therapy with Ginkgo biloba extract EGb 761; group 2 - individuals fitted with digital hearing aids; group 3 - individuals submitted to drug therapy with Ginkgo biloba extract EGb 761 and using hearing aids. The tinnitus handicap inventory and visual analogue scale were used to evaluate self-perception of tinnitus loudness and severity before treatment and 90 days after treatment.
This study demonstrated a significant correlation between tinnitus handicap inventory and visual analogue scale, before and after treatment. We observed a significant improvement in self-perception of tinnitus loudness and severity after 90 days of treatment with Ginkgo biloba extract EGb 761 and/or hearing aids. No correlation was found between tinnitus onset time and self-perception of tinnitus loudness and severity. Hearing aids were more effective in patients with a shorter tinnitus onset time and Ginkgo biloba extract was effective regardless of tinnitus duration.
It was possible to prove the effectiveness of the hearing aids and/or Ginkgo biloba extract EGb 761 treatment, which shows success in the control of tinnitus contributing to the improvement of this symptom.
耳鸣是指在环境中不存在实际声音的情况下感知到声音。它已经成为大量研究的主题,尤其是考虑到它对患者生活质量的影响。
本研究旨在调查助听器和/或银杏叶提取物 EGb 761 对听力损失患者耳鸣的影响。
这是一项随机对照治疗试验,平行、双盲、三臂。33 名成年受试者分为三组:第 1 组-接受银杏叶提取物 EGb 761 药物治疗的受试者;第 2 组-佩戴数字助听器的个体;第 3 组-接受银杏叶提取物 EGb 761 药物治疗和使用助听器的个体。耳鸣残疾量表和视觉模拟量表用于评估治疗前和治疗后 90 天的耳鸣响度和严重程度的自我感知。
本研究表明,治疗前后耳鸣残疾量表和视觉模拟量表之间存在显著相关性。我们观察到,银杏叶提取物 EGb 761 和/或助听器治疗 90 天后,耳鸣响度和严重程度的自我感知有显著改善。耳鸣发作时间与耳鸣响度和严重程度的自我感知之间无相关性。助听器在耳鸣发作时间较短的患者中更有效,而银杏叶提取物无论耳鸣持续时间如何都有效。
可以证明助听器和/或银杏叶提取物 EGb 761 治疗的有效性,这表明它在控制耳鸣方面取得了成功,有助于改善这种症状。